This is a great quarterly publication (.pdf here) from the Federal Reserve Bank of Boston examining the next tier cities/regions (sans the Valley, Boston, NYC, SoCal & Texas) and the venture capital activity therein. The piece identifies factors that may explain how smaller cities attract venture capital. If you do not have the bandwidth to [...]

• 165http://clsdf.com/2007/03/fed-says%e2%80%a6boulder-1-in-deal-activity/Fed+Says%E2%80%A6Boulder+%231+in+Deal+Activity%212007-03-20+15%3A46%3A00admin

I spent some time updating my other blog OnBioVC. For those unfamiliar with it…I am creating a free dBase, tracking life science related venture financings that may be searched and sorted by funding round, geographic locale and lead indication. At the end of each quarter I will post a quantitative/qualitative summary. 1Q07 is nearing an [...]

• 164http://clsdf.com/2007/03/updated-onbiovc-com-1q07-report-soon/Updated+OnBioVC.com+-+1Q07+Report+Soon2007-03-19+01%3A53%3A00admin

The Business of Biotech Network, a collection of 12 biotech and pharma related blogs, is growing by leaps and bounds. The network is now flirting with a near aggregate of 2,000 RSS feed subscriptions. I have also added a new widget to the side-rail so that it is simple to subscribe to any of the [...]

• 163http://clsdf.com/2007/03/business-of-biotech-network-update/Business+of+Biotech+Network+Update2007-03-16+14%3A30%3A00admin

Mike Bristow, M.D., Ph.D. and founder of Myogen recently spoke at the Holland & Hart Bioentrepreneur club. I thought it would be an interesting exercise to see what would happen if the talk was broadcast LIVE. Admittedly, there may have been a secondary desire to see if I may increase traffic to this blog by [...]

• 162http://clsdf.com/2007/03/dr-mike-bristow-live-a-success/Dr.+Mike+Bristow+LIVE%3A+A+Success%212007-03-12+06%3A47%3A00admin

BioCentury: The Bernstein Report on BioBusiness recently featured ApopLogic Pharmaceuticals in their weekly publication. As a trusted global leader in the distribution of biobusiness intelligence it makes me feel all warm inside that the publication is sourcing stories in our own backyard. ApopLogic is a pre-clinical company focused on apoptosis-inducing compounds. Six patents have been [...]

• 161http://clsdf.com/2007/03/apoplogic-pharma-featured-in-biocentury/ApopLogic+Pharma+Featured+in+BioCentury2007-03-12+06%3A11%3A00admin

LIVE Thursday 8:00 – 9:00am MST Dr. Bristow was the principal founder, chief science & medical officer and director of Myogen. In November of 2006 Gilead acquired Myogen for $52.50/share or a whopping $2.5 billion! Dr. Bristow is Professor of Medicine and the former Head of Cardiology, University of Colorado Health Sciences Center, the Co-Director [...]

• 160View 1 Comment...http://clsdf.com/2007/03/mike-bristow-m-d-ph-d-live-broadcast/Mike+Bristow%2C+M.D.%2C+Ph.D.+LIVE+Broadcast2007-03-07+05%3A48%3A00admin